|
US7445924B2
(en)
*
|
2000-11-23 |
2008-11-04 |
Bavarian Nordic A/S |
Modified Vaccinia Ankara virus variant and cultivation method
|
|
US7145057B2
(en)
|
2002-02-01 |
2006-12-05 |
Origen Therapeutics, Inc. |
Chimeric bird from embryonic stem cells
|
|
US20060191026A1
(en)
|
2005-02-18 |
2006-08-24 |
Origen Therapeutics, Inc. |
Tissue specific expression of antibodies in chickens
|
|
FR2836924B1
(fr)
|
2002-03-08 |
2005-01-14 |
Vivalis |
Lignees de cellules aviaires utiles pour la production de substances d'interet
|
|
UA85543C2
(ru)
*
|
2002-09-05 |
2009-02-10 |
Бавариан Нордик А/С |
Способ культивирования первичных клеток и амплификации вирусов в условиях безсывороточной среды, композиция и ее применение, и способ лечения или вакцинации животных
|
|
CA2510229A1
(en)
*
|
2002-12-13 |
2004-07-08 |
Aventis Pasteur, Inc. |
Production of alvac on avian embryonic stem cells
|
|
EP1500699A1
(en)
*
|
2003-07-22 |
2005-01-26 |
Vivalis |
Production of vaccinia virus with adherent or non adherent avian cell lines
|
|
JP4787156B2
(ja)
*
|
2003-07-22 |
2011-10-05 |
ビバリス |
付着または非付着の鳥類細胞系を用いた、ポックスウィルスの作製法
|
|
US20070275010A1
(en)
*
|
2003-09-18 |
2007-11-29 |
Mark Feinberg |
Mva Vaccines
|
|
EP2848692B1
(en)
|
2004-05-21 |
2017-08-16 |
Novartis Vaccines and Diagnostics, Inc. |
Alphavirus vectors for influenza virus vaccines
|
|
EP2578229B1
(en)
|
2004-09-09 |
2013-07-10 |
Novartis Vaccines and Diagnostics GmbH |
Decreasing potential iatrogenic risks associated with vaccine antigens
|
|
EP1807116B1
(en)
|
2004-11-03 |
2015-05-06 |
Novartis Vaccines and Diagnostics, Inc. |
Influenza vaccination
|
|
FR2878860A1
(fr)
*
|
2004-12-08 |
2006-06-09 |
Vivalis Sa |
Lignees de cellules souches humaines derivees de cellules es et utilisations pour la production de vaccins et de proteines recombinantes
|
|
AU2011253998B2
(en)
*
|
2005-04-11 |
2014-04-24 |
Valneva |
Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
|
|
FR2884255B1
(fr)
*
|
2005-04-11 |
2010-11-05 |
Vivalis |
Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
|
|
CN101365480B
(zh)
|
2005-11-01 |
2014-11-05 |
诺华疫苗和诊断有限两合公司 |
经由β-丙内酯处理的残留细胞DNA水平降低的细胞衍生病毒疫苗
|
|
EA014028B1
(ru)
|
2005-11-04 |
2010-08-30 |
Новартис Вэксинс Энд Диагностикс Срл |
Эмульсии, содержащие свободное поверхностно-активное вещество в водной фазе в качестве адъюванта сплит вакцин против гриппа
|
|
WO2007052058A1
(en)
|
2005-11-04 |
2007-05-10 |
Novartis Vaccines And Diagnostics Srl |
Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
|
|
HUE051122T2
(hu)
|
2005-11-04 |
2021-03-01 |
Seqirus Uk Ltd |
Sejttenyészetben növesztett influenzavírusból elõállított nemvirion anti-géneket tartalmazó adjuvált vakcinák
|
|
NZ592713A
(en)
|
2005-11-04 |
2012-12-21 |
Novartis Vaccines & Diagnostic |
Adjuvanted influenza vaccines including a cytokine-inducing agents other than an agonist of Toll-Like Receptor 9
|
|
AU2006310163B2
(en)
|
2005-11-04 |
2011-09-15 |
Seqirus UK Limited |
Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
|
|
HUE049580T2
(hu)
|
2006-01-27 |
2020-09-28 |
Seqirus Uk Ltd |
Hemagglutinint és mátrixfehérjéket tartalmazó, influenza elleni oltóanyagok
|
|
FR2898909A1
(fr)
|
2006-03-24 |
2007-09-28 |
Agronomique Inst Nat Rech |
Combinaison de marqueurs de cellules aviaires
|
|
CN101448523A
(zh)
|
2006-03-24 |
2009-06-03 |
诺华疫苗和诊断有限两合公司 |
无需冷藏储存流感疫苗
|
|
GB0614460D0
(en)
|
2006-07-20 |
2006-08-30 |
Novartis Ag |
Vaccines
|
|
EP2500417A1
(en)
|
2006-08-09 |
2012-09-19 |
Vivalis |
Method of production of transgenic avian using embryonic stem cells
|
|
EP4585610A3
(en)
|
2006-09-11 |
2025-09-24 |
Seqirus UK Limited |
Making influenza virus vaccines without using eggs
|
|
PL2121011T3
(pl)
|
2006-12-06 |
2014-10-31 |
Novartis Ag |
Szczepionki zawierające antygeny czterech szczepów wirusa grypy
|
|
CN100443588C
(zh)
*
|
2006-12-11 |
2008-12-17 |
中国农业科学院北京畜牧兽医研究所 |
静宁鸡胚成纤维细胞系及其培养方法
|
|
EP1985305A1
(en)
*
|
2007-04-24 |
2008-10-29 |
Vivalis |
Duck embryonic derived stem cell lines for the production of viral vaccines
|
|
EP1995309A1
(en)
*
|
2007-05-21 |
2008-11-26 |
Vivalis |
Recombinant protein production in avian EBx® cells
|
|
CN101784283A
(zh)
|
2007-06-27 |
2010-07-21 |
诺华有限公司 |
低添加流感疫苗
|
|
CN101688182A
(zh)
*
|
2007-07-03 |
2010-03-31 |
特兰斯吉恩股份有限公司 |
永生化禽细胞系
|
|
US20090028831A1
(en)
*
|
2007-07-23 |
2009-01-29 |
University Of Kentucky Research Foundation |
Stem cell regulator, compositions and methods of use
|
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
|
US8685654B2
(en)
|
2007-12-24 |
2014-04-01 |
Novartis Ag |
Assays for adsorbed influenza vaccines
|
|
US8506966B2
(en)
|
2008-02-22 |
2013-08-13 |
Novartis Ag |
Adjuvanted influenza vaccines for pediatric use
|
|
KR101445433B1
(ko)
*
|
2008-02-25 |
2014-09-26 |
백스터 인터내셔널 인코포레이티드 |
연속 세포주 제조 방법
|
|
EA201071086A1
(ru)
|
2008-03-18 |
2011-04-29 |
Новартис Аг |
Усовершенствованный способ получения вакцинных антигенов вируса гриппа
|
|
WO2009132195A1
(en)
*
|
2008-04-23 |
2009-10-29 |
Michigan State University |
Immortal avian cell line and methods of use
|
|
EP2379598B1
(en)
|
2009-01-19 |
2015-03-11 |
Innate Pharma |
Anti-kir3d antibodies
|
|
EP2396031A1
(en)
|
2009-02-10 |
2011-12-21 |
Novartis AG |
Influenza vaccines with increased amounts of h3 antigen
|
|
US20120093859A1
(en)
|
2009-02-10 |
2012-04-19 |
Novartis Ag |
Influenza vaccine regimens for pandemic-associated strains
|
|
EP3173097A3
(en)
|
2009-02-10 |
2017-07-12 |
Seqirus UK Limited |
Influenza vaccines with reduced amounts of squalene
|
|
CN102548577A
(zh)
|
2009-04-27 |
2012-07-04 |
诺华有限公司 |
用于抵抗流感的佐剂疫苗
|
|
SI3178490T1
(sl)
|
2009-07-15 |
2022-08-31 |
Glaxosmithkline Biologicals S.A. |
Sestavki proteina F RSV-ja in postopki za pripravo le-teh
|
|
US20120237536A1
(en)
|
2009-09-10 |
2012-09-20 |
Novartis |
Combination vaccines against respiratory tract diseases
|
|
GB0918830D0
(en)
|
2009-10-27 |
2009-12-09 |
Glaxosmithkline Biolog Niederl |
Process
|
|
GB0919117D0
(en)
|
2009-10-30 |
2009-12-16 |
Glaxosmithkline Biolog Sa |
Process
|
|
CA2725435C
(en)
|
2009-12-15 |
2023-01-03 |
University Of Saskatchewan |
Vaccines for inclusion body hepatitis
|
|
US20120309056A1
(en)
|
2010-02-04 |
2012-12-06 |
Leon Arnaud |
Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
|
|
FR2956409A1
(fr)
|
2010-02-15 |
2011-08-19 |
Univ Claude Bernard Lyon |
Procedes pour optimiser la production virale par l'inactivation ou l'inhibition du gene hipk2 et cellules modifiees pour la production virale
|
|
AU2011225748A1
(en)
|
2010-03-08 |
2012-09-13 |
Novartis Ag |
Methods of testing for intracellular pathogens
|
|
EP2374816B1
(en)
|
2010-04-07 |
2016-09-28 |
Agency For Science, Technology And Research |
Binding molecules against Chikungunya virus and uses thereof
|
|
WO2011124635A1
(en)
|
2010-04-07 |
2011-10-13 |
Humalys |
Binding molecules against chikungunya virus and uses thereof
|
|
US9744228B2
(en)
|
2010-04-07 |
2017-08-29 |
Norvartis Ag |
Method for generating a parvovirus B19 virus-like particle
|
|
EP2566323A2
(en)
|
2010-05-06 |
2013-03-13 |
Novartis AG |
Organic peroxide compounds for microorganism inactivation
|
|
EP2571520B1
(en)
|
2010-05-21 |
2018-04-04 |
Seqirus UK Limited |
Influenza virus reassortment method
|
|
AU2011262309B2
(en)
|
2010-06-01 |
2015-08-13 |
Seqirus UK Limited |
Concentration of influenza vaccine antigens without lyophilization
|
|
AU2011262312B2
(en)
|
2010-06-01 |
2015-05-28 |
Novartis Ag |
Concentration and lyophilization of influenza vaccine antigens
|
|
EP3153578A1
(en)
|
2010-07-06 |
2017-04-12 |
Novartis Ag |
Norovirus derived immunogenic compositions and methods
|
|
GB201011502D0
(en)
|
2010-07-08 |
2010-08-25 |
Glaxosmithkline Biolog Sa |
Novel process
|
|
US9517205B2
(en)
|
2010-08-20 |
2016-12-13 |
Seqirus UK Limited |
Soluble needle arrays for delivery of influenza vaccines
|
|
US10214722B2
(en)
|
2010-09-07 |
2019-02-26 |
Technion Research & Development Foundation Limited |
Methods for expanding and maintaining human pluripotent stem cells (PSCs) in an undifferentiated state in a single cell suspension culture
|
|
FR2967072B1
(fr)
|
2010-11-05 |
2013-03-29 |
Univ Dundee |
Procede pour ameliorer la production de virus et semences vaccinales influenza
|
|
WO2012095514A1
(en)
|
2011-01-14 |
2012-07-19 |
Vivalis |
Recombinant protein production system
|
|
HRP20190791T1
(hr)
|
2011-01-26 |
2019-06-28 |
Glaxosmithkline Biologicals Sa |
Režim imuniziranja protiv rsv
|
|
SI3275892T1
(sl)
|
2011-05-13 |
2020-06-30 |
Glaxosmithkline Biologicals S.A. |
Prefuzijski RSV F antigeni
|
|
EP2729168A2
(en)
|
2011-07-06 |
2014-05-14 |
Novartis AG |
Immunogenic compositions and uses thereof
|
|
CA2840989A1
(en)
|
2011-07-06 |
2013-01-10 |
Novartis Ag |
Immunogenic combination compositions and uses thereof
|
|
TWI623618B
(zh)
|
2011-07-12 |
2018-05-11 |
傳斯堅公司 |
Hbv聚合酶突變體
|
|
WO2013045668A2
(en)
|
2011-09-29 |
2013-04-04 |
Transgene Sa |
Immunotherapy composition and regimen for treating hepatitis c virus infection
|
|
WO2013045658A1
(en)
|
2011-09-29 |
2013-04-04 |
Transgene Sa |
Immunotherapy composition and regimen for treating hepatitis c virus infection
|
|
EP2766385A2
(en)
|
2011-10-12 |
2014-08-20 |
Novartis AG |
Cmv antigens and uses thereof
|
|
GB201216121D0
(en)
|
2012-09-10 |
2012-10-24 |
Novartis Ag |
Sample quantification by disc centrifugation
|
|
WO2013057715A1
(en)
|
2011-10-20 |
2013-04-25 |
Novartis Ag |
Adjuvanted influenza b virus vaccines for pediatric priming
|
|
EP2660316A1
(en)
|
2012-05-02 |
2013-11-06 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Avian cell line and its use in production of protein
|
|
JP2015522580A
(ja)
|
2012-07-06 |
2015-08-06 |
ノバルティス アーゲー |
免疫学的組成物およびその使用
|
|
WO2014009433A1
(en)
|
2012-07-10 |
2014-01-16 |
Transgene Sa |
Mycobacterium resuscitation promoting factor for use as adjuvant
|
|
US10357555B2
(en)
|
2012-07-10 |
2019-07-23 |
Transgene Sa |
Mycobacterial antigen vaccine
|
|
GB201218195D0
(en)
|
2012-10-10 |
2012-11-21 |
Istituto Zooprofilattico Sperimentale Delle Venezie |
Composition
|
|
BR112015011389A2
(pt)
|
2012-11-20 |
2017-08-22 |
Glaxosmithkline Biologicals Sa |
Complexo f do vírus sincicial respiratório, métodos para produzir um complexo f do vírus sincicial respiratório e para indução de uma resposta imunológica a um f de rsv em um indivíduo, e, composição imunogênica
|
|
US20140255447A1
(en)
*
|
2013-03-05 |
2014-09-11 |
Biomune Company |
Production of avian embryo cells
|
|
FR3008992A1
(fr)
*
|
2013-07-25 |
2015-01-30 |
Agronomique Inst Nat Rech |
Procede de selection d'une lignee cellulaire permissive pour la replication de virus aviaires
|
|
RU2695462C2
(ru)
|
2014-01-09 |
2019-07-23 |
Трансген Са |
Гибридизация гетероолигомерных микобактериальных антигенов
|
|
EP2974739A1
(en)
|
2014-07-15 |
2016-01-20 |
Novartis AG |
RSVF trimerization domains
|
|
EP3031822A1
(en)
|
2014-12-08 |
2016-06-15 |
Novartis AG |
Cytomegalovirus antigens
|
|
US11118238B2
(en)
|
2014-12-17 |
2021-09-14 |
Fundación Para La Investigación Mèdica Aplicada |
Nucleic acid constructs and gene therapy vectors for use in the treatment of Wilson's disease and other conditions
|
|
HUE055002T2
(hu)
|
2014-12-17 |
2021-10-28 |
Fundacion Para La Investig Medica Aplicada |
Nukleinsav-konstrukciók és génterápiás vektorok Wilson-kór kezelésében történõ alkalmazásra
|
|
EP3047856A1
(en)
|
2015-01-23 |
2016-07-27 |
Novartis AG |
Cmv antigens and uses thereof
|
|
BR112017028011A2
(pt)
|
2015-06-26 |
2018-08-28 |
Seqirus Uk Ltd |
vacinas de gripe correspondentes antigenicamente
|
|
CN108027371B
(zh)
|
2015-07-07 |
2020-08-18 |
思齐乐 |
流感效力试验
|
|
BR112019019813A2
(pt)
|
2017-03-30 |
2020-04-22 |
Univ Queensland |
moléculas quiméricas e usos das mesmas
|
|
EP4400174A3
(en)
|
2017-09-01 |
2024-10-23 |
The Francis Crick Institute Limited |
Immunoregulatory molecules and uses therefor
|
|
CN111727259B
(zh)
|
2017-12-01 |
2024-04-19 |
编码治疗公司 |
工程化的dna结合蛋白
|
|
EP3794127A1
(en)
|
2018-05-14 |
2021-03-24 |
Vivet Therapeutics |
Gene therapy vectors comprising s/mar sequences
|
|
MX2020012895A
(es)
|
2018-05-30 |
2021-05-27 |
Inst Res Biomedicine |
Modificacion de linfocitos b al utilizar citidina desaminasa inducida por activacion endogena.
|
|
WO2020012037A1
(en)
|
2018-07-13 |
2020-01-16 |
Valneva Se |
Method for rescuing and producing a virus in avian cells
|
|
EP4223320B1
(en)
|
2018-10-12 |
2025-06-18 |
Vivet Therapeutics |
Codon-optimized transgene for the treatment of progressive familiar intrahepatic cholestasis type 3 (pfic3)
|
|
WO2020094693A1
(en)
|
2018-11-07 |
2020-05-14 |
Vivet Therapeutics |
Codon-optimized abcb11 transgene for the treatment of progressive familial intrahepatic cholestasis type 2 (pfic2)
|
|
US20210369870A1
(en)
|
2018-11-16 |
2021-12-02 |
Encoded Therapeutics, Inc. |
Compositions and methods for treating wilson's disease
|
|
KR20210094554A
(ko)
|
2018-11-23 |
2021-07-29 |
발네바 에스이 |
조류 줄기 세포를 포함하는 식품
|
|
US12467038B2
(en)
|
2019-05-22 |
2025-11-11 |
Hadasit Medical Research Services And Development Ltd. |
Methods of culturing human pluripotent cells
|
|
CN114174520B
(zh)
|
2019-05-29 |
2025-07-08 |
编码治疗公司 |
用于选择性基因调节的组合物和方法
|
|
WO2021001377A1
(en)
|
2019-07-02 |
2021-01-07 |
Fundacion Para La Investigacion Medica Aplicada |
cPLA2e INDUCING AGENTS AND USES THEREOF
|
|
US20220273789A1
(en)
|
2019-07-21 |
2022-09-01 |
Glaxosmithkline Biologicals Sa |
Therapeutic viral vaccine
|
|
EP4004018A1
(en)
|
2019-07-24 |
2022-06-01 |
GlaxoSmithKline Biologicals SA |
Modified human cytomegalovirus proteins
|
|
AU2020344163A1
(en)
*
|
2019-09-10 |
2022-03-31 |
Vital Meat |
Avian stem cells for the production of a food product
|
|
MX2022006005A
(es)
|
2019-11-18 |
2022-10-27 |
Seqirus Pty Ltd |
Metodo para producir virus de la influenza reagrupados.
|
|
CA3181024A1
(en)
|
2020-08-06 |
2022-02-10 |
Fundacion Para La Investigacion Medica Aplicada |
Viral particles for use in treating tauopathies such as alzheimer's diseases by gene therapy
|
|
US20230265456A1
(en)
|
2020-08-10 |
2023-08-24 |
Fundacion Para La Investigacion Medica Aplicada |
Gene therapy vector expressing cyp27a1 for the treatment of cerebrotendinous xanthomatosis
|
|
CN116390935A
(zh)
|
2020-10-09 |
2023-07-04 |
Ucb生物制药有限责任公司 |
核酸构建体、病毒载体和病毒颗粒
|
|
WO2022136616A1
(en)
|
2020-12-23 |
2022-06-30 |
Vivet Therapeutics |
Minimal bile acid inducible promoters for gene therapy
|
|
EP4032547A1
(en)
|
2021-01-20 |
2022-07-27 |
GlaxoSmithKline Biologicals S.A. |
Hsv1 fce derived fragements for the treatment of hsv
|
|
MX2024005171A
(es)
|
2021-10-28 |
2024-05-13 |
UCB Biopharma SRL |
Constructos de acido nucleico, vectores viricos y particulas viricas.
|
|
WO2023144665A1
(en)
|
2022-01-28 |
2023-08-03 |
Glaxosmithkline Biologicals Sa |
Modified human cytomegalovirus proteins
|
|
CN114480286B
(zh)
*
|
2022-02-16 |
2024-05-31 |
上海健士拜生物科技有限公司 |
无血清悬浮型lmh细胞系及其制备方法和应用
|
|
CN116656628A
(zh)
*
|
2023-07-31 |
2023-08-29 |
深圳市卫光生物制品股份有限公司 |
一种痘病毒载体疫苗的制备方法
|
|
EP4567102A1
(en)
|
2023-12-05 |
2025-06-11 |
Suprême |
Methods for isolating embryonic stem cells from avian embryonic cells
|
|
CN118956737A
(zh)
*
|
2024-07-17 |
2024-11-15 |
广州沃亘生物科技有限公司 |
一种长期维持df-1细胞活力的培养基及其用途
|